Finance

Lists
Q3 2026 earnings • released • EPS beat +11.92% • Revenue beat +0.49%
See results
EHC:NYSE
Encompass Health Corp
$136.33
+0.32%
(+0.43) 1D
Nov 2, 9:30:19 AM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EHC...
Open
$136.31
High
$137.23
Low
$136.31
Mkt. cap
13.45B
Avg. vol.
1.10M
Volume
231.00
Dividend
0.62%
Quarterly dividend
$0.21
Ex-dividend date
Oct 1, 2026
P/E ratio
21.31
52-wk high
$137.27
52-wk low
$92.77
EPS
$6.40
Beta
0.75
Shares outstanding
98.65M
No. of employees
30K
Open
$136.31
High
$137.23
Low
$136.31
Mkt. cap
13.45B
Avg. vol.
1.10M
Volume
231.00
Dividend
0.62%
Quarterly dividend
$0.21
Ex-dividend date
Oct 1, 2026
P/E ratio
21.31
52-wk high
$137.27
52-wk low
$92.77
EPS
$6.40
Beta
0.75
Shares outstanding
98.65M
No. of employees
30K
News stories
From web sources and news partners
Profile
Encompass Health Corporation, formerly Amcare and HealthSouth, based in Birmingham, Alabama, is the United States's largest provider of inpatient rehabilitative services, offering facility-based care through its network of 173 inpatient rehabilitation hospitals located in 39 states and Puerto Rico. Encompass Health's hospitals focus on providing rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The company operated a home health and hospice business that was spun off as Enhabit in 2022. From 1996 to 2003, executives at the company committed accounting fraud on a large scale, leading to a scandal and financial restructuring. Wikipedia
About Encompass Health Corp
CEOMark J. Tarr
Employees30.2K
FoundedFeb 22, 1984
HeadquartersBirmingham, Alabama, United States
SectorHealth care provider
Analyst ratings
Based on 10 analysts giving stock ratings to EHC in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for EHC in the last 3 months.
Highest
Current $136.33
$165.00 (+21.03%)
Average
$150.56 (+10.44%)
Lowest
$140.00 (+2.69%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Langston
TD Cowen
Buy
Maintained
$150.00
+10%
10/30/2026
A.J. Rice
UBS
Buy
Reiterated
$165.00
+21%
10/30/2026
Matthew Gillmor CFA
KeyBanc
Buy
Reiterated
$150.00
+10%
10/30/2026
Joanna Gajuk
Bank of America Securities
Buy
Reiterated
$157.00
+15.2%
10/29/2026
Andrew Mok CFA
Barclays
Buy
Maintained
$151.00
+10.8%
10/29/2026
Andrew Cooper
Raymond James
Buy
Reiterated
$150.00
+10%
09/28/2026
Pito Chickering
Deutsche Bank
Buy
Maintained
$142.00
+4.2%
09/18/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
$140.00
+2.7%
08/11/2026
David S Macdonald
Truist Financial
Buy
Maintained
$150.00
+10%
08/11/2026
Parker Snure
Raymond James
Buy
Maintained
$150.00
+10%
08/07/2026
Jared Haase
William Blair
Buy
Reiterated
-
-
08/05/2026
Unknown Analyst
Stephens
Buy
Reiterated
$140.00
+2.7%
05/04/2026
Kevin Fischbeck
Bank of America Securities
Buy
Reiterated
$150.00
+10%
05/01/2026
Last report
Oct 29, 2026
Fiscal period
Q3 2026
$1.52 / $1.36
+11.92%beat
Revenue / Est. (USD)
1.61B / 1.60B
+0.49%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.54B
1.59B
1.60B
1.61B
Cost of goods sold
865.60M
882.40M
886.40M
905.70M
Cost of revenue
865.60M
882.40M
886.40M
905.70M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
88.20M
73.40M
77.30M
74.90M
Operating expense
395.60M
402.60M
422.60M
415.80M
Total operating expenses
1.26B
1.28B
1.31B
1.32B
Operating income
283.40M
301.60M
288.40M
288.00M
Other non operating income
3.70M
1.20M
9.10M
1.90M
EBT including unusual items
257.70M
288.70M
261.60M
257.80M
EBT excluding unusual items
257.70M
271.40M
264.80M
257.80M
Income tax expense
55.40M
56.40M
53.60M
53.40M
Effective tax rate
21.50%
19.54%
20.49%
20.71%
Other operating expenses
221.00M
241.90M
254.90M
245.20M
Net income
146.10M
194.50M
153.90M
149.90M
Net profit margin
9.46%
12.26%
9.63%
9.31%
Earnings per share
1.46
1.60
1.55
1.52
Interest and investment income
-
-
-
-
Interest expense
-30.20M
-31.80M
-32.80M
-32.20M
Net interest expenses
-30.20M
-31.80M
-32.80M
-32.20M
Depreciation and amortization charges
86.40M
87.30M
90.40M
95.70M
EBITDA
369.80M
388.90M
378.80M
383.70M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps